Anonymous
Guest
Anonymous
Guest
Central question is do these contracts attempt to monopolize? Answer: yes.
Why else would the Sanofi-Merck contracts require market share use concentration metrics, across multiple vaccines and specific mention of exclusion of competitive product's use. And for whose benefit? It certainly is not the patients.
Of course, Merck is going to defend their legitimate use. But if Microsoft could go down, so too could Merck.
Why else would the Sanofi-Merck contracts require market share use concentration metrics, across multiple vaccines and specific mention of exclusion of competitive product's use. And for whose benefit? It certainly is not the patients.
Of course, Merck is going to defend their legitimate use. But if Microsoft could go down, so too could Merck.